NASDAQ: VTGN
Vistagen Therapeutics Revenue

Vistagen Therapeutics revenue was $2.38M for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2026) ending on Sep 30, 2026 was $138.0k, down 90.7% from last quarter. For the last reported fiscal year 2026 ending Mar 31, 2026, VTGN annual revenue was $1.3M, with 161.1% growth year-over-year.

VTGN past revenue growth

How has VTGN's revenue growth performed historically?

Company
230.37%
Industry
79.34%
Market
22.39%
VTGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VTGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
VTGN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

VTGN revenue history

Current Revenue
$2.4M
Current Earnings
-$58.9M
Current Profit Margin
-2,474.5%

Be the first to know when VTGN announces revenue.

VTGN Revenue History By Year

VTGN Yearly RevenueVTGN RevenueVTGN ChangeVTGN Revenue Growth
2026-03-31$1.27M$783.00k+161.11%
2025-03-31$486.00k-$578.00k-54.32%
2024-03-31$1.06M$1.29M-568.72%
2023-03-31-$227.00k-$1.34M-120.47%
2022-03-31$1.11M$19.40k+1.78%
2021-03-31$1.09MN/AN/A
2020-03-31$0.00N/AN/A
2019-03-31$0.00N/AN/A
2018-03-31$0.00-$1.25M-100.00%
2017-03-31$1.25MN/AN/A
2016-03-31$0.00N/AN/A
2015-03-31$0.00N/AN/A
2014-03-31$0.00-$200.40k-100.00%
2013-03-31$200.40k-$1.14M-85.07%
2012-03-31$1.34M-$728.80k-35.19%
2011-03-31$2.07MN/AN/A

1 of 2

Vistagen Therapeutics Revenue FAQ

What was VTGN's revenue last quarter?

On Nov 13, 2026, Vistagen Therapeutics (NASDAQ: VTGN) reported Q3 2026 revenue of $138.00 thousand up 46.51% year over year. In the same quarter last year, Vistagen Therapeutics's revenue was $258.00 thousand.

What was Vistagen Therapeutics's revenue in 2026?

Vistagen Therapeutics's annual revenue for the twelve months ending Mar 31, 2026 was $1.27 million, a 161.11% increase year over year.

How much does Vistagen Therapeutics make in a day?

Based on Vistagen Therapeutics annual revenue for the past five years, VTGN makes an average of $2,027.89 per day.

What was Vistagen Therapeutics's annual revenue growth in the past year?

As of Q4 2026, Vistagen Therapeutics's revenue has grown 230.37% year over year. This is 151.04 percentage points higher than the US Biotechnology industry revenue growth rate of 79.34%. Vistagen Therapeutics's revenue in the past year totaled $2.38 million.

How much does Vistagen Therapeutics make in a year?

Vistagen Therapeutics's revenue by year for the past five years is:
  • Vistagen Therapeutics's revenue for the twelve months ending Mar 31, 2026 was $1.27 million, a 161.11% increase year over year.
  • Vistagen Therapeutics's annual revenue for Mar 31, 2025 was $486.00 thousand, a 54.32% decrease from 2024.
  • Vistagen Therapeutics's annual revenue for 2024 was $1.06 million, a 568.72% decrease from 2023.
  • Vistagen Therapeutics's annual revenue for 2023 was -$227.00 thousand, a 120.47% decrease from 2022.
  • Vistagen Therapeutics's annual revenue for 2022 was $1.11 million, a 1.78% increase from 2021.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.